Abstract
In search of new inhibitors of the Ser/Thr protein kinase PknB from Mycobacterium tuberculosis we carried out a structure-based virtual screening study to identify ATP-competitive inhibitors of this enzyme. These studies point out that N-phenylmethylindole-2-carboxamide is a promising scaffold for the development of new PknB inhibitors. We synthesized a small set of analogue compounds to assess the pharmacophore structural requirements and to optimize the inhibitory activity against PknB. This strategy led to the identification of compound 3, endowed with an IC50 of 20 μM, which provides a novel scaffold for further improvement of PknB inhibitors.
Keywords: Ser, Thr protein kinase PknB, mycobacterium tuberculosis, virtual screening, indole.
Letters in Drug Design & Discovery
Title:Structure-based Virtual Screening to Get New Scaffold Inhibitors of the Ser/Thr Protein Kinase PknB from Mycobacterium tuberculosis
Volume: 13 Issue: 10
Author(s): Antonio Coluccia, Giuseppe La Regina, Nathalie Barilone, María-Natalia Lisa, Andrea Brancale, Gwenaëlle André-Leroux, Pedro M. Alzari and Romano Silvestri
Affiliation:
Keywords: Ser, Thr protein kinase PknB, mycobacterium tuberculosis, virtual screening, indole.
Abstract: In search of new inhibitors of the Ser/Thr protein kinase PknB from Mycobacterium tuberculosis we carried out a structure-based virtual screening study to identify ATP-competitive inhibitors of this enzyme. These studies point out that N-phenylmethylindole-2-carboxamide is a promising scaffold for the development of new PknB inhibitors. We synthesized a small set of analogue compounds to assess the pharmacophore structural requirements and to optimize the inhibitory activity against PknB. This strategy led to the identification of compound 3, endowed with an IC50 of 20 μM, which provides a novel scaffold for further improvement of PknB inhibitors.
Export Options
About this article
Cite this article as:
Coluccia Antonio, Regina La Giuseppe, Barilone Nathalie, Lisa María-Natalia, Brancale Andrea, André-Leroux Gwenaëlle, Alzari M. Pedro and Silvestri Romano, Structure-based Virtual Screening to Get New Scaffold Inhibitors of the Ser/Thr Protein Kinase PknB from Mycobacterium tuberculosis, Letters in Drug Design & Discovery 2016; 13 (10) . https://dx.doi.org/10.2174/1570180813666160801162204
DOI https://dx.doi.org/10.2174/1570180813666160801162204 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
4-Hydroxy-3-methoxyphenyl Substituted 3-methyl-tetrahydroquinoline Derivatives Obtained Through Imino Diels-Alder Reactions as Potential Antitumoral Agents
Letters in Drug Design & Discovery Formulation Strategies and Particle Engineering Technologies for Pulmonary Delivery of Biopharmaceuticals
Current Pharmaceutical Design MIANN Models in Medicinal, Physical and Organic Chemistry
Current Topics in Medicinal Chemistry Artemisia Species as Potential Weapon Against Agents and Agricultural Pests
Current Biotechnology Beneficial Effects of Liposomal Formulations of Lichen Substances: A Review
Current Drug Delivery Recent Advances Using Phosphodiesterase 4 (PDE4) Inhibitors to Treat Inflammatory Disorders: Animal and Clinical Studies
Current Drug Therapy Meet Our Editorial Board Member:
Current Medicinal Chemistry Meet Our Editorial Board Member:
Current HIV Research Phylogenetic and Functional Classification of ATP-Binding Cassette (ABC) Systems
Current Protein & Peptide Science Recent Advances in the Development of Novel Therapeutics Targeting Dendritic Cells
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Biology of gama delta T Cells in Tuberculosis and Malaria
Current Molecular Medicine Patent Selections
Recent Patents on Anti-Infective Drug Discovery Fish and Apoptosis: Studies in Disease and Pharmaceutical Design
Current Pharmaceutical Design Iron Metabolism: A Promising Target for Antibacterial Strategies
Recent Patents on Anti-Infective Drug Discovery Dihydrofolate Reductase as a Model for Enzyme Catalysis
Current Biotechnology 2-Aminoimidazole, Glycociamidine and 2-Thiohydantoin-Marine Alkaloids as Molecular Inspirations for the Development of Lead Structures
Current Drug Targets miR-202 Mediates Metabolic Shift in Lung Cancer Cells via Targeting HK2
Current Signal Transduction Therapy Recent Updates on Biological Activities of Oxadiazoles
Mini-Reviews in Medicinal Chemistry Graphical Abstracts
Medicinal Chemistry In Silico Identification of Human miR 3654 and its Targets Revealed its Involvement in Prostate Cancer Progression
MicroRNA